Premium
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS
Author(s) -
Lunning M.,
Horwitz S.,
Advani R.,
Vose J.,
Lee H.,
MehtaShah N.,
Zain J.,
Haverkos B.,
Lechowicz M.,
Moskowitz A.,
Heires P.,
Lyden L.,
Ansell S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.91_2630
Subject(s) - medicine , lenalidomide , vincristine , phases of clinical research , gastroenterology , international prognostic index , clinical endpoint , progression free survival , regimen , autologous stem cell transplantation , surgery , etoposide , cyclophosphamide , oncology , transplantation , multiple myeloma , chemotherapy , clinical trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom